Newsroom
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
Phase 3 READY program of its proprietary, liquid formulation of an investigational botulinum toxin is fully enrolled.
Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
Phase 3 READY program of its proprietary, liquid formulation of an investigational botulinum toxin is fully enrolled.
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
Company to Hold GAIN Live Webinar with DREAM Investigator Tomorrow, May 13, at 7 p.m. CDT.
Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year
Company to Hold GAIN Live Webinar with DREAM Investigator Tomorrow, May 13, at 7 p.m. CDT.
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
New RESTYLANE® HA Filler lasts for up to 1 year1,2 using XpresHAn Technology™.
Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
New RESTYLANE® HA Filler lasts for up to 1 year1,2 using XpresHAn Technology™.
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China
First approval for a class III medical device for improved skin appearance in China.
Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China
First approval for a class III medical device for improved skin appearance in China.
Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*
Business-building webinars to support local Aesthetic practices. Expert injector techniques by GAIN faculty.
Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*
Business-building webinars to support local Aesthetic practices. Expert injector techniques by GAIN faculty.
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies
Ten Data Releases Will Be Presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.
Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies
Ten Data Releases Will Be Presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.
Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines
Azzalure (marketed as Dysport outside of the EU) for the treatment of glabellar lines marks 10 year anniversary.
Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines
Azzalure (marketed as Dysport outside of the EU) for the treatment of glabellar lines marks 10 year anniversary.